IIT Courses In 2026: IITs now offer several courses and programmes that students can pursue without JEE scores.

While JEE Main and Advanced remain mandatory for core undergraduate engineering degrees, IITs are steadily opening their ...

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2026 / New to The Street, the nationally syndicated, long-form ...

The Andrew Hillman Grant for Biotech is established to encourage forward-thinking students who demonstrate a strong interest in how biotechnology shapes the future of healthcare, medicine, and society ...

CRISPR Therapeutics’ fourth quarter was relatively disappointing. As a biotech start-up still in its infancy though, these early quarterly numbers don’t mean much. The foreseeable future looks bright ...

Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it’s no mystery as to why many wish to be underweight in ...

The head of biomedical research at Novartis spoke with STAT about AI, pruning the pipeline, and a potential blockbuster.

FBT returned 29% over the past year and gained 5.4% in the first week of 2026. Federal Reserve officials forecast another 150 basis points of rate cuts in 2026. Healthcare stocks trade at some of the ...

Abivax stock rallied in 2025, far outpacing peers, as the French biotech surprised investors with a stellar data readout in July for its lead asset – an ulcerative colitis medicine. Now, analysts say ...

Carolina Canastillo, 17, poured a packet of powder into a beaker containing clear liquid. Upon making contact with the powder — a substance nicknamed “DPD,” which can be used to measure chlorine ...

2025 market gains were strong but heavily concentrated in megacap tech, setting up a potential 2026 rotation toward broader participation. I expect a neutral-to-slightly positive 2026 for SPY, with ...